Open Label Extension Study of Eculizumab in Patients With Transfusion Dependent PNH
Latest Information Update: 02 Nov 2023
At a glance
- Drugs Eculizumab (Primary)
- Indications Paroxysmal nocturnal haemoglobinuria
- Focus Adverse reactions
- Sponsors Alexion Pharmaceuticals
Most Recent Events
- 08 Jun 2017 New trial record